Abstract
Hepatocyte growth factor (HGF) has been shown to have multiple effects on the wound healing process. Several in vitro and ex vivo models using HGF have been shown to promote wound healing. The expression of HGF and its receptor cMet are different in chronic and acute wounds. HGF treatments in chronic wounds have not lived up to the expectations of the in vitro and ex vivo models. This review looks at the different expression of the HGF receptor and HGF agonists in chronic wounds compared to acute wounds. This aberrant expression may have a value in identifying early the wounds at risk of becoming chronic. A greater understanding of HGF and HGF agonists expression will have a direct implication for a protein engineering approach to the management of chronic wounds.
Keywords: HGF, HGF agonists, c-Met, wound healing, Matriptase, Keratinocyte, proteolytic
Current Signal Transduction Therapy
Title: HGF and HGF Agonists, Expression in Wound and Potential Role in the Management of Wound Healing
Volume: 6 Issue: 2
Author(s): Kevin Conway
Affiliation:
Keywords: HGF, HGF agonists, c-Met, wound healing, Matriptase, Keratinocyte, proteolytic
Abstract: Hepatocyte growth factor (HGF) has been shown to have multiple effects on the wound healing process. Several in vitro and ex vivo models using HGF have been shown to promote wound healing. The expression of HGF and its receptor cMet are different in chronic and acute wounds. HGF treatments in chronic wounds have not lived up to the expectations of the in vitro and ex vivo models. This review looks at the different expression of the HGF receptor and HGF agonists in chronic wounds compared to acute wounds. This aberrant expression may have a value in identifying early the wounds at risk of becoming chronic. A greater understanding of HGF and HGF agonists expression will have a direct implication for a protein engineering approach to the management of chronic wounds.
Export Options
About this article
Cite this article as:
Conway Kevin, HGF and HGF Agonists, Expression in Wound and Potential Role in the Management of Wound Healing, Current Signal Transduction Therapy 2011; 6 (2) . https://dx.doi.org/10.2174/157436211795659919
DOI https://dx.doi.org/10.2174/157436211795659919 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?
Current Cancer Drug Targets Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery
Current Medicinal Chemistry SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy
Current Topics in Medicinal Chemistry Inflammatory Cytokines in Acute Ischemic Stroke
Current Pharmaceutical Design Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents
Current Organic Synthesis Palladium-Catalyzed Oxyarylation, Azaarylation and α-Arylation Reactions in the Synthesis of Bioactive Isoflavonoid Analogues
Current Organic Synthesis Intramolecular Processes and Their Applications in Prodrugs Approaches- Experimental and Computational Studies
Current Organic Chemistry Deep Inspiration Breath-hold (DIBH) Technique to Reduce Cardiac Radiation Dose in the Management of Breast Cancer
Current Cancer Therapy Reviews c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Stress-Activated MAP Kinase Cascades in Cellular Senescence
Current Medicinal Chemistry Screening Novel SAHA Derivatives as Anti-lung Carcinoma Agents: Synthesis, Biological Evaluation, Docking Studies and Further Mechanism Research between Apoptosis and Autophagyetween Apoptosis and Autophagy
Anti-Cancer Agents in Medicinal Chemistry Thrombomodulin – A New Target for Treating Stroke at the Crossroad of Coagulation and Inflammation
Current Medicinal Chemistry Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases
Current Topics in Medicinal Chemistry SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Current Pharmaceutical Design ErbB Antagonists Patenting: “Playing Chess with Cancer”
Recent Patents on Biotechnology Weekly Low-doses with Prolonged Infusion of Gemcitabine /Cisplatin for Multi-treated Metastatic Breast Cancer Patients
Current Cancer Therapy Reviews Effectiveness of Psychoeducational Interventions for Improving Symptoms, Health-Related Quality of Life, and Psychological well Being in Patients with Stable Angina
Current Cardiology Reviews Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases
Current Cancer Drug Targets Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line
Current Drug Discovery Technologies Editorial (Thematic Issue: Focal Adhesion Kinase and Cross-Linked Signaling In Cancer)
Anti-Cancer Agents in Medicinal Chemistry